Position in CRSP
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$14,767,032
-$10,939,370 QoQ
Shares Held
270,756
-44.8% QoQ
Ownership
0.280%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#37
of 521 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRSP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. CRSP ranks #37 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,971,681 | $1,476,123,103 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,172,808 | $731,292,700 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,271,813 | $683,883,867 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
8,207,954 | $469,659,127 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
2,157,479 | $404,052,667 | |
| 6 | INSM |
INSMED Inc
|
3,377,641 | $360,124,083 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,896,536 | $317,606,649 | |
| 8 | RPRX |
Royalty Pharma plc
|
5,336,084 | $299,194,229 |
All Filings in CRSP
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $14,767,032 | 270,756 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $25,706,402 | 490,206 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $19,771,527 | 406,487 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $15,519,721 | 456,060 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $17,457,576 | 443,536 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $19,337,343 | 411,608 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $35,117,734 | 650,208 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $40,232,666 | 590,268 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $38,660,883 | 617,586 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $26,612,157 | 586,300 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $32,394,632 | 577,033 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $28,479,159 | 629,652 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $29,082,148 | 715,428 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $43,573,288 | 666,768 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $35,889,364 | 590,577 | Shares | Sole | 2023-08-14 | |
| 2022-03-31 | $38,530,297 | 613,833 | Shares | Sole | 2023-05-12 | |
| 2021-12-31 | $44,917,609 | 592,737 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $74,501,391 | 665,607 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $101,033,930 | 624,090 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $67,780,402 | 556,261 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $86,214,863 | 563,091 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $47,874,448 | 572,387 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $36,633,148 | 498,478 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $6,900,827 | 162,717 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||